NAUT
Nautilus Biotechnology IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$327.80M
P/E Ratio
—
EPS
$-0.46
Beta
0.99
52W High
$4.31
52W Low
$0.62
50-Day MA
$2.90
200-Day MA
$1.76
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Nautilus Biotechnology Inc
Nautilus Biotechnology, Inc., a development-stage life sciences company, is dedicated to creating platform technology to quantify and unlock proteome complexity. The company is headquartered in Seattle, Washington.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-65.08M |
| Operating Margin | 0.00% |
| Return on Equity | -32.30% |
| Return on Assets | -19.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.24 |
| Price-to-Book | 2.27 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.00 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $126.56M |
| Float | $46.03M |
| % Insiders | 33.48% |
| % Institutions | 44.99% |
Historical Volatility
HV 10-Day
63.43%
HV 20-Day
76.85%
HV 30-Day
105.20%
HV 60-Day
104.17%
HV Rank
62.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($4.00 target)
2
BuyData last updated: 4/29/2026